Earnings4534Mochida Pharmaceutical Co.,Ltd.
Mochida Pharmaceutical Reports Q1 Revenue of 31.7 billion, Up 19%
TOKYO, Aug 03 (Pulse News Wire) – Mochida Pharmaceutical Co., Ltd. (4534.T) reported consolidated results for Q1 FY2027 (ending March 2027).
Revenue was ¥31.7 billion (+19.1% YoY). operating profit was ¥3,564 million (+38.5%). net profit attributable to shareholders was ¥3,178 million (+67.8%).
Total assets stood at ¥180 billion with an equity ratio of 77.3%. The company declared an annual dividend of ¥42 per share. The full-year forecast for the current fiscal year is revenue of ¥130 billion (+7.7%).
Financial results — FY2027/3 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥31,719M | +19.1% |
| Operating profit | ¥3,564M | +38.5% |
| Net profit | ¥3,178M | +67.8% |
Next period forecast
Revenue
¥126,000M
+7.7%Op. profit
¥10,500M
+3.5%Net profit
¥10,000M
+26.5%Source: TDNet filing · Figures in millions of yen
End of article